Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (5)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Wilcox, M. H.
Right arrow Articles by Fawley, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wilcox, M. H.
Right arrow Articles by Fawley, W.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Journal of Antimicrobial Chemotherapy (2001) 48, 144-145
© 2001 The British Society for Antimicrobial Chemotherapy

Correspondence

Extremely low prevalence of UK Staphylococcus aureus isolates with reduced susceptibility to vancomycin

Mark H. Wilcox*, and Warren Fawley

Department of Microbiology, University of Leeds and The General Infirmary, Leeds LS2 9JT, UK

Sir,

We note with interest that Livermore and colleagues have not detected any Staphylococcus aureus isolates with reduced susceptibility to vancomycin despite screening approximately 26 000 strains.1 Since April 2000, in our department, all isolates . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Antimicrob ChemotherHome page
S. Mushtaq, M. Warner, Y. Ge, K. Kaniga, and D. M. Livermore
In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes
J. Antimicrob. Chemother., August 1, 2007; 60(2): 300 - 311.
[Abstract] [Full Text] [PDF]

Home page
 Antimicrob. Agents Chemother.Home page
D. M. Livermore, M. Warner, S. Mushtaq, S. North, and N. Woodford
In Vitro Activity of the Oxazolidinone RWJ-416457 against Linezolid-Resistant and -Susceptible Staphylococci and Enterococci
Antimicrob. Agents Chemother., March 1, 2007; 51(3): 1112 - 1114.
[Abstract] [Full Text] [PDF]

Home page
 J Bone Joint Surg BrHome page
M. Al-Maiyah, D. Hill, A. Bajwa, S. Slater, P. Patil, A. Port, and P. J. Gregg
Bacterial contaminants and antibiotic prophylaxis in total hip arthroplasty
J Bone Joint Surg Br, September 1, 2005; 87-B(9): 1256 - 1258.
[Abstract] [Full Text] [PDF]

Home page
 J Antimicrob ChemotherHome page
R. Paton, T. Snell, F. X. S. Emmanuel, and R. S. Miles
Glycopeptide resistance in an epidemic strain of methicillin-resistant Staphylococcus aureus
J. Antimicrob. Chemother., December 1, 2001; 48(6): 941 - 942.
[Full Text] [PDF]